Ovid Therapeutics Inc. (OVID)
USD 1.01
(-4.72%)
USD 1.01
(-4.72%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 391.69 Thousand | 1.5 Million | 208.38 Million | 12.61 Million | - | - |
| Cost of Revenue | 1.59 Million | 1.38 Million | - | - | 255 Thousand | 141.73 Thousand |
| Gross Profit | -1.2 Million | 121.14 Thousand | 208.38 Million | 12.61 Million | -255 Thousand | -141.73 Thousand |
| Operating Expenses | 59.67 Million | 57.05 Million | 84.17 Million | 94.04 Million | 61.4 Million | 52.93 Million |
| Selling, General and Administrative Expenses | 31.08 Million | 32.43 Million | 37.23 Million | 30.63 Million | 19.25 Million | 19.14 Million |
| Research and Development Expenses | 28.58 Million | 24.61 Million | 46.93 Million | 63.41 Million | 42.15 Million | 33.79 Million |
| Other Expenses | 1.00 | 1.37 Million | -45.69 Thousand | 395.4 Thousand | - | - |
| Cost and Expenses | 59.67 Million | 57.05 Million | 84.17 Million | 94.04 Million | 61.4 Million | 52.93 Million |
| Operating Income | -59.28 Million | -55.54 Million | 124.2 Million | -81.43 Million | -61.4 Million | -52.93 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -2.76 Million | 1.32 Million | -306.84 Thousand | -1.2 Million | 951.72 Thousand |
| Earnings before Tax | -52.33 Million | -54.16 Million | 124.16 Million | -81.03 Million | -60.46 Million | -51.97 Million |
| Net Income | -52.33 Million | -51.4 Million | 122.83 Million | -80.72 Million | -59.25 Million | -51.97 Million |
| Earnings Per Share Basic | -0.74 | -0.73 | 1.78 | -1.38 | -1.51 | -2.11 |
| Earnings Per Share Diluted | -0.74 | -0.73 | 1.78 | -1.38 | -1.51 | -2.11 |
| Weighted Average Shares Outstanding | 70.58 Million | 70.42 Million | 67.47 Million | 58.45 Million | 39.21 Million | 24.63 Million |
| Weighted Average Shares Outstanding (Diluted) | 70.58 Million | 70.42 Million | 68.06 Million | 58.45 Million | 39.21 Million | 24.63 Million |
| Gross Margin | -3.08 | 0.08 | 1.00 | 1.00 | - | - |
| EBIT Margin | -149.90 | -36.96 | 0.60 | -6.45 | - | - |
| Profit Margin | -133.62 | -34.21 | 0.59 | -6.40 | - | - |
| EBITDA | -58.71 Million | -52.78 Million | 124.4 Million | -81.12 Million | -60.2 Million | -52.78 Million |
| Earnings Before Tax Margin | -151.35 | -36.96 | 0.60 | -6.45 | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 169 Thousand | 148 Thousand | 141.56 Thousand | 391.69 Thousand | 108.97 Thousand | 75 Thousand |
| Cost of Revenue | 148 Thousand | 136 Thousand | 401.39 Thousand | 1.59 Million | -108.86 Million | -74.92 Million |
| Gross Profit | 21 Thousand | 12 Thousand | -259.83 Thousand | -1.2 Million | 108.97 Million | 75 Million |
| Operating Expenses | 20.53 Million | 17.42 Million | 17.92 Million | 58.07 Million | 12.13 Million | 14.24 Million |
| Selling, General and Administrative Expenses | 8.05 Million | 7.13 Million | 7.38 Million | - | 6.8 Million | 8.24 Million |
| Research and Development Expenses | 12.47 Million | 10.29 Million | 10.54 Million | - | 5.33 Million | 5.99 Million |
| Other Expenses | 29.03 Million | 5.72 Million | -4.07 Million | - | 776.44 Thousand | 1.76 Million |
| Cost and Expenses | 20.68 Million | 17.56 Million | 18.32 Million | 59.67 Million | 12.13 Million | 14.24 Million |
| Operating Income | -20.51 Million | -17.41 Million | -18.18 Million | -59.28 Million | -12.02 Million | -14.17 Million |
| Interest Expense | - | - | 1.53 Billion | - | - | - |
| Income Tax Expense | - | 92.72 Thousand | -2.00 | 5.00 | 213.00 | 216.00 |
| Earnings before Tax | 8.52 Million | -11.69 Million | -15.32 Million | -52.33 Million | -11.25 Million | -12.4 Million |
| Net Income | 8.52 Million | -11.69 Million | -15.32 Million | -52.33 Million | -11.25 Million | -12.4 Million |
| Earnings Per Share Basic | 0.12 | -0.17 | -0.22 | - | -0.16 | -0.18 |
| Earnings Per Share Diluted | 0.12 | -0.17 | -0.22 | - | -0.16 | -0.18 |
| Weighted Average Shares Outstanding | 70.91 Million | 70.71 Million | 70.68 Million | 70.58 Million | 70.61 Million | 70.53 Million |
| Weighted Average Shares Outstanding (Diluted) | 70.91 Million | 70.71 Million | 70.68 Million | 70.58 Million | 70.61 Million | 70.53 Million |
| Gross Margin | 0.12 | 0.08 | -1.84 | -3.08 | 1000.00 | 1000.00 |
| EBIT Margin | -120.53 | -116.76 | -125.65 | - | -106.69 | -183.69 |
| Profit Margin | 50.42 | -79.01 | -108.24 | -133.62 | -103.26 | -165.44 |
| EBITDA | -20.36 Million | -17.28 Million | -17.78 Million | - | -11.62 Million | -13.77 Million |
| Earnings Before Tax Margin | -121.40 | -117.68 | -128.48 | -151.35 | -110.38 | -188.96 |
STCN
NWE
FINOPB
TMHC
TIPT
SECCF